Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

Promega's Cookie Policy

We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we won’t set them unless you accept them. To find out more about cookies and how to manage cookies, read our Cookie Policy.

NanoLuc™: A Smaller, Brighter and More Stable Luciferase Reporter

Part # PS155

Abstract

Brock Binkowski, Mary Hall, Braedy Butler, Matt Robers, James Unch*, Kris Zimmerman, Paul Otto, Gedi Vidugiris, Monika Wood, Mike Slater, Lance Encell, Frank Fan and Keith Wood
Promega Corporation, 2800 Woods Hollow Rd Madison, WI 53711; *Promega BioSciences

NanoLuc™ (Nluc) is an ATP-independent luciferase that utilizes a novel coelenterazine analog (furimazine) to produce high intensity, glow-type luminescence. The enzyme, evolved from a deep-sea shrimp, is much brighter than firefly luciferase (Fluc) and provides superior sensitivity as a genetic reporter. It exhibits greater physical stability, which reduces compound interference in high-throughput screening (HTS). NanoLuc™ may be configured for intracellular or secreted reporter formats, and being less than 1/3 the size of Fluc, it is well suited for experiments requiring small reporters (e.g., viral genomes, protein fusions, etc.).

Printed in USA.